NASDAQ:NRIX | Cash Flow Statement | Nurix Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2019-02-28 to 2026-05-31
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-05-31-$89.54M
2026-02-28-$87.17M-$71.91M$1.05M-$123.83M$19.98M
2025-11-30-$78.22M-$67.83M$5.13M$346,000.00$236.01M
2025-08-31-$86.42M
2025-05-31-$43.46M
2025-02-28-$56.35M-$61.09M$3.49M$25.53M$1.47M
2024-11-30-$58.55M-$48.75M$2.11M-$140.82M$200.52M
2024-08-31-$48.96M
2024-05-31-$44.55M
2024-02-29-$41.52M-$41.95M$2.88M$35.51M$1.62M
2023-11-30-$41.96M$26.69M$2.59M-$14.37M$7,000.00
2023-08-31-$36.98M
2023-05-31-$24.28M
2023-02-28-$40.73M-$48.45M$2.28M$16.07M$1.48M
2022-11-30-$46.72M-$37.96M$2.57M$55.01M-$135,000.00
2022-08-31-$45.71M
2022-05-31-$45.4M
2022-02-28-$42.53M-$42.63M$3.47M$40.03M$1.49M
2021-11-30-$37.7M-$30.91M$862,000.00-$36.52M$500,000.00
2021-08-31-$28.84M
2021-05-31-$26.38M
2021-02-28-$24.28M$8.05M$843,000.00-$2.39M$1.36M
2020-11-30-$19.91M-$20.48M$906,000.00-$124.56M-$1.13M
2020-08-31-$18.52M
2020-05-31$7.58M
2020-02-29-$12.39M$40.97M$364,000.00-$19.42M$46,000.00
2019-11-30-$13.52M-$12.75M$953,000.00-$4.37M$80,000.00
2019-08-31-$2.43M
2019-05-31-$3.07M
2019-02-28-$2.69M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-11-30-$264.46M-$249.47M$14M$147.85M$238.64M
2024-11-30-$193.57M-$172.58M$9.27M-$257.71M$485.67M
2023-11-30-$143.95M-$81.37M$8.4M$68.3M$3.22M
2022-11-30-$180.36M-$159.81M$12.24M$27.2M$117.19M
2021-11-30-$117.19M-$84.37M$5.66M-$108.25M$153.88M
2020-11-30-$43.24M-$80,000.00$4.55M-$254.4M$339.02M
2019-11-30-$21.7M$601,000.00$1.65M$8.5M$126,000.00